Literature DB >> 12090644

Improved strategies and new treatment options for allergic rhinitis.

Sandra K Willsie1.   

Abstract

Primary principles relevant to the clinical management of allergic rhinitis include (1) avoidance of allergens and triggering factors, (2) use of appropriate pharmacotherapy, (3) evaluation regarding need for and appropriate use of immunotherapy, and (4) patient education and follow-up. Currently available pharmacotherapeutic options include oral and topical (intranasal) decongestants and corticosteroids, mast cell stabilizers, intranasal anticholinergics, and antihistamines. Future therapeutic options include leukotriene modifiers and anti-IgE antibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12090644

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  4 in total

Review 1.  The safety and efficacy of desloratadine for the management of allergic disease.

Authors:  William E Berger
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  The relationship of intranasal steroids to intraocular pressure.

Authors:  Joseph Bergmann; Matthew T Witmer; Charles B Slonim
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

3.  Biyuanling suppresses the toluene-2, 4-diisocyanate induced allergic rhinitis in guinea pigs.

Authors:  Meixian Xiang; Li Wu; Hanwen Su; Bing Han; Huanxiang Liu; Xincai Xiao; Xian Yin; Ya Fan; Lang Zhang; Yuying Huang; Lei Zhao; Guangzhong Yang
Journal:  Oncotarget       Date:  2017-12-08

4.  A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study).

Authors:  Pedro Ojeda; Núria Piqué; Alicia Alonso; Julio Delgado; Francisco Feo; Juan Manuel Igea; Ana Navarro; José María Olaguibel; Javier Subiza; Carles Nieto; Morgan Andersson
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-27       Impact factor: 3.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.